These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 37198517)

  • 1. Correlation between sKL and Nrf2 plasma levels and calcium oxalate urolithiasis.
    Aihemaitijiang B; Ruotian L; Qi Y; Mahemuti M
    Int Urol Nephrol; 2023 Jul; 55(7):1671-1676. PubMed ID: 37198517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Idiopathic recurrent calcium urolithiasis (IRCU): variation of fasting urinary protein is a window to pathophysiology or simple consequence of renal stones in situ? A tripartite study in male patients providing insight into oxidative metabolism as possible driving force towards alteration of urine composition, calcium salt crystallization and stone formation.
    Schwille PO; Schmiedl A; Wipplinger J
    Eur J Med Res; 2009 Sep; 14(9):378-92. PubMed ID: 19748857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mineralogical composition of urinary stones, risk factors and metabolic disturbances in patients with calcium-oxalate urolithiasis].
    Kustov AV; Strelnikov AI; Moryganov MA; Airapetyan AO; Smirnov PR; Lyalyakina EV; Toms SR
    Urologiia; 2017 Sep; (4):22-26. PubMed ID: 28952687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antioxidative activity and clinical efficiency of dietary supplements Nefradoz for treatment of recurrent calcium oxalate urolithiasis].
    Kamalov AA; Okhobotov DA; Proskurnina EV; Sozarukova MM; Nizov AN
    Urologiia; 2018 Dec; (6):52-59. PubMed ID: 30742378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can 24-hour urine stone risk profiles predict urinary stone composition?
    Torricelli FC; De S; Liu X; Calle J; Gebreselassie S; Monga M
    J Endourol; 2014 Jun; 28(6):735-8. PubMed ID: 24460026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circadian clock gene BMAL1 reduces urinary calcium oxalate stones formation by regulating NRF2/HO-1 pathway.
    Wang J; Bai Y; Yin S; Cui J; Zhang Y; Wang X; Zhang F; Li H; Tang Y; Wang J
    Life Sci; 2021 Jan; 265():118853. PubMed ID: 33278384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is calcium oxalate nucleation in postprandial urine of males with idiopathic recurrent calcium urolithiasis related to calcium phosphate nucleation and the intensity of stone formation? Studies allowing insight into a possible role of urinary free citrate and protein.
    Schwille PO; Schmiedl A; Manoharan M
    Clin Chem Lab Med; 2004 Mar; 42(3):283-93. PubMed ID: 15080561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Determination of calcium metabolism markers concentration in patients with calcium oxalate nephrolithiasis].
    Porhanov VA; Medvedev VL; Budanov AA; Kurzanov AN; Basov AA
    Urologiia; 2021 Mar; (1):60-65. PubMed ID: 33818937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of maternal and paternal history on stone composition and clinical course of calcium nephrolithiasis in subjects aged between 15 and 25.
    Guerra A; Ticinesi A; Allegri F; Nouvenne A; Pinelli S; Folesani G; Lauretani F; Maggio M; Borghi L; Meschi T
    Urolithiasis; 2016 Nov; 44(6):521-528. PubMed ID: 27038481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Klotho inhibits the formation of calcium oxalate stones by regulating the Keap1-Nrf2-ARE signaling pathway.
    Ahmatjan B; Ruotian L; Rahman A; Bin M; Heng D; Yi H; Tao C; le G; Mahmut M
    Int Urol Nephrol; 2023 Feb; 55(2):263-276. PubMed ID: 36336747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence and risk factors for urolithiasis recurrence after endourological management of kidney stones: A retrospective single-centre study.
    Baowaidan F; Zugail AS; Lyoubi Y; Culty T; Lebdai S; Brassart E; Bigot P
    Prog Urol; 2022 Jul; 32(8-9):601-607. PubMed ID: 35314101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elucidation of factors determining formation of calcium phosphate stones.
    Pak CY; Adams-Huet B
    J Urol; 2004 Dec; 172(6 Pt 1):2267-70. PubMed ID: 15538246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic assessment of recurrent and first renal calcium oxalate stone formers.
    Çakıroğlu B; Eyyupoğlu E; Hazar AI; Uyanik BS; Nuhoğlu B
    Arch Ital Urol Androl; 2016 Jul; 88(2):101-5. PubMed ID: 27377084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of Dietary Oxalate and Oxalate Precursors to Urinary Oxalate Excretion.
    Crivelli JJ; Mitchell T; Knight J; Wood KD; Assimos DG; Holmes RP; Fargue S
    Nutrients; 2020 Dec; 13(1):. PubMed ID: 33379176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the protein content of kidney stones: an explorative study.
    Steenbeke M; De Buyzere ML; Speeckaert MM; Delanghe JR
    Acta Clin Belg; 2022 Oct; 77(5):845-852. PubMed ID: 34743670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autophagy-endoplasmic reticulum stress inhibition mechanism of superoxide dismutase in the formation of calcium oxalate kidney stones.
    Kang J; Sun Y; Deng Y; Liu Q; Li D; Liu Y; Guan X; Tao Z; Wang X
    Biomed Pharmacother; 2020 Jan; 121():109649. PubMed ID: 31733571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic abnormalities and the medical management of calcium oxalate nephrolithiasis.
    Chandhoke PS
    Minerva Urol Nefrol; 2005 Mar; 57(1):9-16. PubMed ID: 15944517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is idiopathic recurrent calcium urolithiasis in males a cellular disease? Laboratory findings in plasma, urine and erythrocytes, emphasizing the absence and presence of stones, oxidative and mineral metabolism: an observational study.
    Schwille PO; Manoharan M; Schmiedl A
    Clin Chem Lab Med; 2005; 43(6):590-600. PubMed ID: 16006254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 24 Hour urine metabolic differences between solitary and multiple stone formers: Results of the Collaboration on Urolithiasis in Pediatrics (CUP) working group.
    Saitz TR; Mongoue-Tchokote S; Sharadin C; Giel DW; Corbett S; Kovacevic L; Bayne AP;
    J Pediatr Urol; 2017 Oct; 13(5):506.e1-506.e5. PubMed ID: 28526618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.